二氮烯二醇盐的药理作用、作用机制及应用前景的研究进展
Recent Developments in Pharmacological Effect, Mechanism and Application Prospect of Diazeniumdiolates.
作者信息
Li Bin, Ming Yue, Liu Yao, Xing Haiyan, Fu Ruoqiu, Li Ziwei, Ni Rui, Li Li, Duan Dongyu, Xu Jing, Li Chen, Xiang Mingfeng, Song Hongyu, Chen Jianhong
机构信息
Department of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
出版信息
Front Pharmacol. 2020 Jun 23;11:923. doi: 10.3389/fphar.2020.00923. eCollection 2020.
Abstract
Nitric oxide (NO) is a simple structured and unstable free radical molecule, which participates in the regulation of many pathophysiological processes. It functions both as a second messenger and as an endogenous neurotransmitter. Diazeniumdiolates (NONOates) are a series of compounds containing the functional parent nuclear structure of [N(O)NO], which are the most widely studied NO donors. NONOates are unstable and easy to release NO in physiological conditions. The biomedical applications and drug development of NO donor have attracted the scientists' attention in recent years. In this review, recent advances in NONOates research are highlighted in terms of chemical structures, molecular characteristics, pharmacological effects, and biomedical application prospects.
摘要
一氧化氮（NO）是一种结构简单且不稳定的自由基分子，它参与许多病理生理过程的调节。它既作为第二信使又作为内源性神经递质发挥作用。二氮烯二醇盐（NONOates）是一系列含有[N(O)NO]功能母体核结构的化合物，是研究最为广泛的NO供体。NONOates不稳定，在生理条件下易于释放NO。近年来，NO供体的生物医学应用和药物开发引起了科学家们的关注。在这篇综述中，将从化学结构、分子特征、药理作用和生物医学应用前景等方面重点介绍NONOates研究的最新进展。
相似文献
1
Recent Developments in Pharmacological Effect, Mechanism and Application Prospect of Diazeniumdiolates.二氮烯二醇盐的药理作用、作用机制及应用前景的研究进展
Front Pharmacol. 2020 Jun 23;11:923. doi: 10.3389/fphar.2020.00923. eCollection 2020.
2
Decomposition of amino diazeniumdiolates (NONOates): molecular mechanisms.氨基重氮二醇盐（NONOates）的分解：分子机制
J Inorg Biochem. 2014 Dec;141:28-35. doi: 10.1016/j.jinorgbio.2014.08.008. Epub 2014 Aug 23.
3
The NOtizer--a device for the convenient preparation of diazen-1-ium-1,2-diolates.NOtizer——一种用于方便制备重氮-1,2-二醇盐的装置。
Methods Enzymol. 2005;396:17-26. doi: 10.1016/S0076-6879(05)96002-3.
4
Novel primary amine diazeniumdiolates-Chemical and biological characterization.新型伯胺氮烯二羟酸盐的化学和生物学特性研究。
Drug Dev Res. 2018 May;79(3):136-143. doi: 10.1002/ddr.21428. Epub 2018 May 2.
5
Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators.吸入式二氮烯二醇盐（硝普盐）作为选择性肺血管扩张剂。
Expert Opin Investig Drugs. 2002 Jul;11(7):897-909. doi: 10.1517/13543784.11.7.897.
6
Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities.生成一氧化氮（NO）和硝酰基（HNO）的连二亚硝酸酯（NONOates）：新兴的商业机遇。
Curr Top Med Chem. 2005;5(7):625-36. doi: 10.2174/1568026054679380.
7
Don't just say no: Differential pathways and pharmacological responses to diverse nitric oxide donors.不要只是说不：对不同一氧化氮供体的差异途径和药理学反应。
Biochem Pharmacol. 2018 Oct;156:1-9. doi: 10.1016/j.bcp.2018.08.002. Epub 2018 Aug 3.
8
Diazeniumdiolates: pro- and antioxidant applications of the "NONOates".重氮二醇盐：“NONO 供体”的促氧化和抗氧化应用。
Free Radic Biol Med. 2000 May 15;28(10):1463-9. doi: 10.1016/s0891-5849(00)00251-3.
9
Nitric Oxide-Releasing Polymeric Materials for Antimicrobial Applications: A Review.用于抗菌应用的一氧化氮释放聚合物材料：综述
Antioxidants (Basel). 2019 Nov 15;8(11):556. doi: 10.3390/antiox8110556.
10
Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates.一氧化氮释放二氮烯二醇盐临床应用的进展。
Annu Rev Pharmacol Toxicol. 2003;43:585-607. doi: 10.1146/annurev.pharmtox.43.100901.135831. Epub 2002 Jan 10.
引用本文的文献
1
Nitric Oxide Therapeutics: New Hopes for More Effective Tuberculosis Treatment Combine with Targeted and Controlled Nanotechnology.一氧化氮疗法：更有效治疗结核病的新希望与靶向及可控纳米技术相结合。
Int J Nanomedicine. 2025 Jul 19;20:9195-9218. doi: 10.2147/IJN.S531255. eCollection 2025.
2
Transcriptional responses to nitric oxide are widescale and source-dependent.对一氧化氮的转录反应是广泛存在且依赖于来源的。
J Biol Chem. 2025 Jul 11;301(8):110476. doi: 10.1016/j.jbc.2025.110476.
3
Nitroglycerin-responsive gene switch for the on-demand production of therapeutic proteins.用于按需生产治疗性蛋白质的硝酸甘油响应基因开关。
Nat Biomed Eng. 2025 Feb 14. doi: 10.1038/s41551-025-01350-7.
4
Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer.基于一氧化氮的多协同纳米医学：一种用于抗癌的新兴治疗方法。
J Nanobiotechnology. 2024 Nov 4;22(1):674. doi: 10.1186/s12951-024-02929-z.
5
Nitric oxide-based treatments improve wound healing associated with diabetes mellitus.基于一氧化氮的治疗方法可改善与糖尿病相关的伤口愈合。
Med Gas Res. 2025 Mar 1;15(1):23-35. doi: 10.4103/mgr.MEDGASRES-D-24-00020. Epub 2024 Jul 25.
6
Naphthalimide-based light-induced nitric oxide-releasing nanoscale vesicles with visual detection and cytotoxicity studies.基于萘酰亚胺的光诱导一氧化氮释放纳米囊泡的可视化检测及细胞毒性研究
iScience. 2024 Jun 9;27(7):110230. doi: 10.1016/j.isci.2024.110230. eCollection 2024 Jul 19.
7
The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice.LY487379 或 CDPPB 对小鼠大脑中 eNOS 表达的影响，以及联合使用 NO 释放剂对 MK-801 或东莨菪碱致小鼠认知功能障碍的影响。
Molecules. 2024 Jan 29;29(3):627. doi: 10.3390/molecules29030627.
8
Nitric oxide-releasing prodrug for the treatment of complex infections.用于治疗复杂感染的一氧化氮供体型前药。
Antimicrob Agents Chemother. 2024 Feb 7;68(2):e0132723. doi: 10.1128/aac.01327-23. Epub 2024 Jan 11.
9
Nitric oxide-induced ribosome collision activates ribosomal surveillance mechanisms.一氧化氮诱导核糖体碰撞激活核糖体监控机制。
Cell Death Dis. 2023 Jul 26;14(7):467. doi: 10.1038/s41419-023-05997-5.
10
Human pulmonary microvascular endothelial cell DDAH1-mediated nitric oxide production promotes pulmonary smooth muscle cell apoptosis in co-culture.人肺微血管内皮细胞 DDAH1 介导热激诱导型一氧化氮合酶产生促进共培养中肺平滑肌细胞凋亡。
Am J Physiol Lung Cell Mol Physiol. 2023 Sep 1;325(3):L360-L367. doi: 10.1152/ajplung.00433.2021. Epub 2023 Jul 11.
本文引用的文献
1
Nitric Oxide-Loaded Antimicrobial Polymer for the Synergistic Eradication of Bacterial Biofilm.用于协同根除细菌生物膜的载一氧化氮抗菌聚合物
ACS Macro Lett. 2018 May 15;7(5):592-597. doi: 10.1021/acsmacrolett.8b00190. Epub 2018 May 4.
2
Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A.亚硝脲/NO 供体通过上调 RASSF1 和 CDKN1A 的表达抑制子宫内膜癌细胞的生长。
Molecules. 2019 Oct 16;24(20):3722. doi: 10.3390/molecules24203722.
3
Insights Into Nitric Oxide Modulated Quorum Sensing Pathways.一氧化氮调节群体感应途径的见解
Front Microbiol. 2019 Sep 24;10:2174. doi: 10.3389/fmicb.2019.02174. eCollection 2019.
4
Nitric Oxide-Mediated Enhancement and Reversal of Resistance of Anticancer Therapies.一氧化氮介导的抗癌疗法耐药性增强与逆转
Antioxidants (Basel). 2019 Sep 17;8(9):407. doi: 10.3390/antiox8090407.
5
Targeting nitric oxide as a key modulator of sepsis, arthritis and pain.以一氧化氮为靶点，调节脓毒症、关节炎和疼痛。
Nitric Oxide. 2019 Aug 1;89:32-40. doi: 10.1016/j.niox.2019.04.011. Epub 2019 Apr 30.
6
A polyethylenimine-based diazeniumdiolate nitric oxide donor accelerates wound healing.基于聚乙烯亚胺的硝酮亚氨酸酯一氧化氮供体加速伤口愈合。
Biomater Sci. 2019 Mar 26;7(4):1607-1616. doi: 10.1039/c8bm01519h.
7
Combination Therapy with DETA/NO and Clopidogrel Inhibits Metastasis in Murine Mammary Gland Cancer Models via Improved Vasoprotection.联合应用 DETANO 和氯吡格雷通过改善血管保护抑制小鼠乳腺肿瘤模型的转移。
Mol Pharm. 2018 Nov 5;15(11):5277-5290. doi: 10.1021/acs.molpharmaceut.8b00781. Epub 2018 Oct 4.
8
Don't just say no: Differential pathways and pharmacological responses to diverse nitric oxide donors.不要只是说不：对不同一氧化氮供体的差异途径和药理学反应。
Biochem Pharmacol. 2018 Oct;156:1-9. doi: 10.1016/j.bcp.2018.08.002. Epub 2018 Aug 3.
9
Recent Developments in Drug Design of NO-donor Hybrid Compounds.NO 供体型杂合化合物药物设计的新进展。
Mini Rev Med Chem. 2018;18(14):1175-1198. doi: 10.2174/1389557518666180416150005.
10
Cross-talk between endogenous HS and NO accounts for vascular protective activity of the metal-nonoate Zn(PipNONO)Cl.内源性 HS 和 NO 之间的串扰解释了金属-非诺酸盐 Zn(PipNONO)Cl 的血管保护活性。
Biochem Pharmacol. 2018 Jun;152:143-152. doi: 10.1016/j.bcp.2018.03.025. Epub 2018 Mar 26.
Zotero 插件